News & Events
MedPharm Appoints Bill Humphries as Chief Executive Officer to Lead Next Phase of Strategic Growth
Durham, NC, February 4, 2025 – MedPharm, a global leader in topical and transdermal contract drug development and manufacturing, today announced the appointment of Bill Humphries as Chief Executive Officer. Bill’s leadership will enable MedPharm to accelerate its strategic growth following its merger with Tergus Pharma which significantly bolstered MedPharm’s scientific, clinical trial manufacturing, and […]
MedPharm Welcomes New Board Members, Appoints Industry Veteran Patrick Walsh as Executive Chairman
Guildford, UK and Durham, NC, February 20, 2024 – MedPharm, a global topical and transdermal CDMO, today announced several Board changes,
MedPharm, Ltd. and Tergus Pharma Merger Forms Topical and Transepithelial CDMO Leader
GUILDFORD, United Kingdom and DURHAM, N.C., July 8, 2024 — MedPharm, Ltd., an Ampersand Capital Partners portfolio company, and Tergus Pharma, a Great Point Partners portfolio company, jointly announced today a merger. The combined topical and transepithelial Contract Development and Manufacturing Organization (CDMO) will operate under the MedPharm name, establishing a leading, end-to-end CDMO with robust scientific, clinical trial manufacturing and […]
MedPharm Announces Appointment of New U.S. Director of Analytical
MedPharm, a global CDMO focused on topical and transdermal development and manufacturing, recently announced the appointment of a new U.S. Director
MedPharm collaborates with Mosanna to develop new drug to tackle Metabolic Obstructive Sleep Apnea
MedPharm, a global provider of contract topical and transdermal formulation development and manufacturing services,
MedPharm Shortlisted for Two CPHI Pharma Awards
MedPharm is pleased to announce that it has been selected as a finalist in two CPHI Pharma Award Categories.
Successful MHRA Audit of MedPharm Guildford
MedPharm, a global Contract Development and Manufacturing Organization that specializes in topical and transdermal drug product development,
